Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia ; volume:16 ; number:1 ; day:20 ; month:7 ; year:2016 ; pages:1-8 ; date:12.2016
BMC pulmonary medicine ; 16, Heft 1 (20.7.2016), 1-8, 12.2016
- Creator
- Contributor
-
Bianchini, Sonia
Gambino, Monia
Madini, Barbara
Di Pietro, Giada
Umbrello, Giulia
Presicce, Maria Lory
Ruggiero, Luca
Terranova, Leonardo
Principi, Nicola
SpringerLink (Online service)
- DOI
-
10.1186/s12890-016-0267-4
- URN
-
urn:nbn:de:1111-2016072245419
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Esposito, Susanna
- Bianchini, Sonia
- Gambino, Monia
- Madini, Barbara
- Di Pietro, Giada
- Umbrello, Giulia
- Presicce, Maria Lory
- Ruggiero, Luca
- Terranova, Leonardo
- Principi, Nicola
- SpringerLink (Online service)
Other Objects (12)
Childhood community-acquired pneumonia
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Clinical profile of recurrent community-acquired pneumonia in children
Childhood community-acquired pneumonia
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
Clinical profile of recurrent community-acquired pneumonia in children
Childhood community-acquired pneumonia
Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study
Global trends in community-acquired pneumonia
Diagnostic error in community-acquired pneumonia
Modern treatment of community-acquired Pneumonia (CAP)
Non-infectious mimics of community-acquired pneumonia
Sex and gender differences in community-acquired pneumonia
Computed tomography in children with community-acquired pneumonia
Pharmacotherapy and the risk for community-acquired pneumonia
Community-Acquired Pneumonia in Children: Myths and Facts
Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin